Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Astria Therapeutics, Inc.
< Previous
1
2
Next >
Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
April 09, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 03, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
March 25, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
March 04, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
February 20, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 06, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 05, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
January 30, 2024
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Present STAR-0215 Data at the 2023 World Allergy Congress
November 27, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Present at Upcoming 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update
November 13, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Presents New Phase 1a Data Confirming Potential for STAR-0125 to Prevent Hereditary Angioedema Attacks with Dosing 2 or 4 Times Per Year at the 2023 American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
November 10, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference
November 09, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Present New STAR-0215 Data at the 2023 American College of Allergy, Asthma, And Immunology Annual Scientific Meeting
November 03, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 02, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on Monday, November 13th
October 30, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Pricing of $64 Million Underwritten Offering
October 11, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Exclusive Worldwide License Agreement with Ichnos Sciences for OX40 Portfolio
October 11, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Participate in Upcoming Investor Conferences
September 06, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Publication of STAR-0215 Preclinical Data in the Journal of Pharmacology and Experimental Therapeutics
August 31, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Present Patient Survey Data at Upcoming 2023 HAEi Regional EMEA Conference
August 25, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update
August 07, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Receives Fast Track Designation for STAR-0215 for the Treatment of Hereditary Angioedema
July 20, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Names John Ruesch as Senior Vice President, Pharmaceutical Sciences and Technical Operations
July 17, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics to Present Patient Survey Data at Upcoming 2023 US HAEA National Summit
July 14, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 06, 2023
From
Astria Therapeutics, Inc.
Via
Business Wire
Tickers
ATXS
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.